Week Ahead – w50


Summary Key Macro Events

🇪🇺 🇬🇧 Michel Barnier, the European Union’s chief negotiator, denied that the U.K. and EU are nearing a breakthrough over their longstanding disagreement over fishing, according to officials with knowledge of his comments – Bloomberg (7)

🇺🇸 A bipartisan group of US senators will unveil legislation as early as Monday for additional fiscal stimulus worth about $900bn – FT (7)

🇨🇳 China releases November’s consumer price index, the barometer for inflation (9)

🇨🇦 The Bank of Canada meets Wednesday, with no change in policy expected (9)

🇪🇺 The ECB is set to add another €500bn to its €1.35tn emergency asset purchase programme when it meets on Thursday (10)

🇪🇺 EU leaders will meet in Brussels on Thursday and Friday to discuss core issues for the bloc, including the approval of the next budget along with the €1.8tn recovery package, the ratification of the 2030 climate goals and the Brexit deal as trade talks enter the end game – FT (10 & 11)

🇺🇸 James Hildreth, member of FDA’s vaccine advisory committee, told NBC News a vote will take place Thursday on whether to provide emergency use authorization (EUA) for Pfizer (PFE) and BioNTech’s (BNTX) coronavirus vaccine – The Hill (10)

🇺🇸 CPI for November (10)

🇺🇸 🇨🇳 The U.S. State Department is set to name financial institutions that conduct “significant transactions” with sanctioned individuals who violated the promised autonomy in the former British colony – Nikkei (11)








Focus on 🇺🇸 Economic Calendar



Top 10 Macro/Financial Charts of the Previous Week – w49


What happened in the World Economy last Week – in charts – w49 (Bloomberg)


Partager l'article

Partager sur facebook
Partager sur twitter
Partager sur linkedin
Partager sur print
Partager sur email


Vous souhaitez réaliser une interview, faire appel à moi pour une conférence, vous souhaitez contribuer au blog, ou pour toute autre demande, vous pouvez me joindre directement. Vous trouverez également les coordonnées de Market Securities si vous souhaitez recevoir leur offre de recherche (dédiée aux investisseurs institutionnels).